amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
| Name | E4_AMYLOIDOSIS |
|---|---|
| Long name | Amyloidosis |
| Hospital Discharge registry | ICD-10: E85 |
| Cause of Death registry | ICD-10: E85 |
| Include | E4_AMYL_NONNEURO, E4_AMYL_NEUROHER, E4_AMYL_HEREDOFAM, E4_AMYL_SCNDSYST, E4_AMYL_ORGAN, E4_AMYLNAS |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Amyloidosis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 226 | 117 | 109 |
| Unadjusted prevalence (%) | 0.10 | 0.10 | 0.12 |
| Mean age at first event (years) | 61.13 | 58.30 | 64.16 |
| Case fatality at 5-years (%) | 22.57 | 21.37 | 23.85 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 3.0 | 3.0 | 2.0 |
| Recurrence at 6 months (%) | 57.52 | 58.97 | 55.96 |
before Amyloidosis
after Amyloidosis
Loading survival analyses plot…
Loading survival analyses table…